ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,446, issued on April 21, was assigned to The Methodist Hospital (Houston).
"PSMA-targeted immunotherapies for cancers" was invented by Bin He (Bellaire, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are engineered cells comprising chimeric antigen receptors and uses thereof for treating prostate cancer."
The patent was filed on Aug. 20, 2021, under Application No. 18/032,485.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12605446&OS=12605446&RS=12605446
Disclai...